Skip to main content

Lucy Therapeutics

Cambridge, United States

Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.

$12.5M raised
May 2024
Venture - Series Unknown

Top Investors

Engine VenturesSafar PartnersThe EngineMichael J. Fox FoundationMassachusetts Life Sciences Center

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lucy Therapeutics

How much funding has Lucy Therapeutics raised?
Lucy Therapeutics has raised $12.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Who are Lucy Therapeutics's investors?
Lucy Therapeutics's investors include Engine Ventures, Safar Partners, The Engine, Michael J. Fox Foundation, Massachusetts Life Sciences Center.
Where is Lucy Therapeutics headquartered?
Lucy Therapeutics is headquartered in Cambridge, United States.
What does Lucy Therapeutics do?
Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.
What stage is Lucy Therapeutics at?
Lucy Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Lucy Therapeutics — Funding & Investors." VCBacked, May 28, 2024, https://www.vcbacked.co/company/lucy-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Lucy Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/lucy-therapeutics
Wikipedia (cite web)
{{cite web |title=Lucy Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lucy-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .